Upstream Bioprocessing 2022

Vectors

Upstream Bioprocessing 2022

Upstream Bioprocessing 2022
Achieving better AAV vector productivity and product quality

Achieving better AAV vector productivity and product quality

Diane Golebiowski, Marissa Stanvick
22 July 2022
Podcast
Leveraging a scalable, standardized platform process for suspension-based AAV and LV vector manufacture to accelerate time to clinic

Leveraging a scalable, standardized platform process for suspension-based AAV and LV vector manufacture to accelerate time to clinic

Samira Shore
29 July 2022
FastFacts
Driving significant AAV process yield and quality improvements for systemic delivery

Driving significant AAV process yield and quality improvements for systemic delivery

Rahul Chelikani
29 August 2022
Interview
Why Pall’s Allegro™ Stirred-Tank Bioreactor is ideal for viral vector cell culture

Why Pall’s Allegro™ Stirred-Tank Bioreactor is ideal for viral vector cell culture

E Cameau, E Asilonu, S Bah et al.
28 August 2022
Innovator Insight
Adapting the power of density gradient separations for characterizing viral vector fullness

Adapting the power of density gradient separations for characterizing viral vector fullness

Shawn Sternisha
25 August 2022
Innovator Insight
Complete system for AAV production for clinical production: part 1 – upstream

Complete system for AAV production for clinical production: part 1 – upstream

Jonathan Zmuda, Jenny England
26 October 2022
Innovator Insight

Other editions


<< Back to Vectors channel